Modulating diseased skin with tissue engineering

Actinic purpura treated with Apligraf

Meggan N. Banta, Robert Kirsner

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

BACKGROUND. Actinic purpura (AP) is an important medical issue and quality of life issue in the elderly. Current treatment of AP is limited to prevention of cutaneous aging. OBJECTIVE. To assess the utility of tissue engineered skin (Apligraf, Organogenesis, Canton, MA) as a tissue modulator in diseased skin and as treatment for AP. METHODS. A thin partial-thickness section of AP was removed from the forearm of an elderly gentleman and replaced with fenestrated Apligraf. Healing, durability and cosmetic outcome were assessed. RESULTS. Apligraf-treated skin healed rapidly with good clinical "take." Lack of new skin tears and resultant erosions or ulcer formation suggests improved durability of the Apligraf-treated area occurred. CONCLUSION. These results suggest that tissue engineered skin modulates aged dermal tissue to behave in a more sturdy fashion. Furthermore, in selected cases Apligraf may represent a treatment option for AP.

Original languageEnglish
Pages (from-to)1103-1106
Number of pages4
JournalDermatologic Surgery
Volume28
Issue number12
StatePublished - Dec 1 2002

Fingerprint

Purpura
Tissue Engineering
Skin Diseases
Skin
Skin Aging
Organogenesis
Forearm
Cosmetics
Ulcer
Therapeutics
Quality of Life
Apligraf

ASJC Scopus subject areas

  • Dermatology

Cite this

Modulating diseased skin with tissue engineering : Actinic purpura treated with Apligraf. / Banta, Meggan N.; Kirsner, Robert.

In: Dermatologic Surgery, Vol. 28, No. 12, 01.12.2002, p. 1103-1106.

Research output: Contribution to journalArticle

@article{039d1ea72d904554bd47310c3d5a47fd,
title = "Modulating diseased skin with tissue engineering: Actinic purpura treated with Apligraf",
abstract = "BACKGROUND. Actinic purpura (AP) is an important medical issue and quality of life issue in the elderly. Current treatment of AP is limited to prevention of cutaneous aging. OBJECTIVE. To assess the utility of tissue engineered skin (Apligraf, Organogenesis, Canton, MA) as a tissue modulator in diseased skin and as treatment for AP. METHODS. A thin partial-thickness section of AP was removed from the forearm of an elderly gentleman and replaced with fenestrated Apligraf. Healing, durability and cosmetic outcome were assessed. RESULTS. Apligraf-treated skin healed rapidly with good clinical {"}take.{"} Lack of new skin tears and resultant erosions or ulcer formation suggests improved durability of the Apligraf-treated area occurred. CONCLUSION. These results suggest that tissue engineered skin modulates aged dermal tissue to behave in a more sturdy fashion. Furthermore, in selected cases Apligraf may represent a treatment option for AP.",
author = "Banta, {Meggan N.} and Robert Kirsner",
year = "2002",
month = "12",
day = "1",
language = "English",
volume = "28",
pages = "1103--1106",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Modulating diseased skin with tissue engineering

T2 - Actinic purpura treated with Apligraf

AU - Banta, Meggan N.

AU - Kirsner, Robert

PY - 2002/12/1

Y1 - 2002/12/1

N2 - BACKGROUND. Actinic purpura (AP) is an important medical issue and quality of life issue in the elderly. Current treatment of AP is limited to prevention of cutaneous aging. OBJECTIVE. To assess the utility of tissue engineered skin (Apligraf, Organogenesis, Canton, MA) as a tissue modulator in diseased skin and as treatment for AP. METHODS. A thin partial-thickness section of AP was removed from the forearm of an elderly gentleman and replaced with fenestrated Apligraf. Healing, durability and cosmetic outcome were assessed. RESULTS. Apligraf-treated skin healed rapidly with good clinical "take." Lack of new skin tears and resultant erosions or ulcer formation suggests improved durability of the Apligraf-treated area occurred. CONCLUSION. These results suggest that tissue engineered skin modulates aged dermal tissue to behave in a more sturdy fashion. Furthermore, in selected cases Apligraf may represent a treatment option for AP.

AB - BACKGROUND. Actinic purpura (AP) is an important medical issue and quality of life issue in the elderly. Current treatment of AP is limited to prevention of cutaneous aging. OBJECTIVE. To assess the utility of tissue engineered skin (Apligraf, Organogenesis, Canton, MA) as a tissue modulator in diseased skin and as treatment for AP. METHODS. A thin partial-thickness section of AP was removed from the forearm of an elderly gentleman and replaced with fenestrated Apligraf. Healing, durability and cosmetic outcome were assessed. RESULTS. Apligraf-treated skin healed rapidly with good clinical "take." Lack of new skin tears and resultant erosions or ulcer formation suggests improved durability of the Apligraf-treated area occurred. CONCLUSION. These results suggest that tissue engineered skin modulates aged dermal tissue to behave in a more sturdy fashion. Furthermore, in selected cases Apligraf may represent a treatment option for AP.

UR - http://www.scopus.com/inward/record.url?scp=0036945576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036945576&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 1103

EP - 1106

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 12

ER -